Harrington et al. (Nature, 2008) used cytokine fate-mapping to show that IFN-γ-producing effector CD4 T cells themselves give rise to long-lived memory CD4 T cells, paralleling CD8 T-cell differentiation, but left open the mechanism deciding which effectors survive the contraction phase. The lineage sub-question is now settled affirmatively, while the mechanistic core remains open: no causal, general account specifies the signals, transcriptional programs, and prospective markers that determine which effector CD4 T cells survive contraction to seed memory, how memory derived from distinct effector progenitors (in particular Th1 versus Tfh programs) compares in durability and protective recall, or which features are conserved versus lineage-specific relative to the CD8 memory-precursor framework. A 2025 review dedicated to this exact problem concludes that decisive fate-determination factors across diverse infection conditions have not been revealed and that the field still lacks a general theory of memory CD4 T-cell generation.
Background
Upon infection, naive T lymphocytes that recognize pathogen-derived peptide fragments expand massively and differentiate into effector cells; after the pathogen is cleared, most effector cells die during the 'contraction' phase, while a minority persist as long-lived memory T cells that mount faster and more effective responses upon re-encounter. CD4 T cells are the helper lineage of T lymphocytes: rather than killing infected cells directly, they coordinate other immune cells. Their effector subsets are defined by signature cytokines, notably T helper 1 (Th1) cells, which secrete interferon-γ (IFN-γ, a macrophage-activating and antiviral cytokine), and follicular helper T (Tfh) cells, which support antibody maturation in germinal centers of lymphoid tissues. Other named helper subsets include Th2 cells, which secrete interleukin-4, and Th17 cells, which secrete interleukin-17. Memory CD4 T-cell populations are heterogeneous, comprising central memory (TCM), effector-like memory (TEM) and tissue-resident memory (TRM) cells distinguished by migration and retention markers such as CD62L, CCR7, CD69 and CD103.
For CD8 (cytotoxic) T cells, whose large clonal expansion made them easier to study, a guiding framework was established: at the peak of the effector response, cells with high CD127 (the alpha chain of the interleukin-7 receptor, a survival cytokine receptor) and low KLRG1 behave as memory precursor effector cells (MPECs) that seed memory, whereas CD127-low/KLRG1-high short-lived effector cells (SLECs) mostly die during contraction; the transcription factor TCF1 marks stem-like memory precursors. Whether CD4 memory follows the same logic was long unresolved, because the smaller CD4 effector populations are hard to track. Harrington et al. (2008) addressed this with cytokine reporter and fate-mapping mice (genetic systems that irreversibly label cells at the moment they produce a cytokine), showing that IFN-γ-positive effector CD4 T cells give rise to long-lived memory capable of anamnestic (recall) responses, a lineage relationship parallel to CD8 T cells. Independently, Löhning et al. (2008) generated long-lived virus-reactive memory from purified cytokine-secreting Th1 and Th2 effector cells.
These studies settled the lineage question but left the mechanism open: which of the activated effector cells survive contraction, and why. Later work identified individual contributing factors: opposing actions of the transcription factor Bcl6 and interleukin-2 receptor signaling in generating Th1 central versus effector memory (Pepper et al. 2011); heterogeneity in the transcription factors T-bet and the surface molecule Ly6C that separates effector-like from memory-like Th1 cells (Marshall et al. 2011); high expression of the surface molecule CD47 as a marker of functional long-lived memory progenitors (Van et al. 2012); a late effector 'checkpoint' at which short-lived antigen recognition, rather than infection itself, programs survival into protective memory (Bautista et al. 2016; reviewed in Dhume and McKinstry 2018); the transcription factor Thpok, required for the emergence and functional fitness of memory CD4 T cells and acting by restraining an effector-like program through antagonizing the transcriptional regulators Blimp1 and Runx3 (Ciucci et al. 2019); and the transcriptional coactivator OCA-B/Pou2af1, reported sufficient to promote central-memory formation and to prospectively identify memory precursors during viral infection (Sun et al. 2024). Single-cell transcriptomic and epigenomic work showed that the effector-to-memory transition in CD4 T cells is gradual rather than a sharp branch, with partial resetting of effector heterogeneity in the memory pool (Durek et al. 2016; Soon et al. 2020). Nevertheless, a 2025 review dedicated to identifying precursors of memory CD4 T cells concludes that no general model exists: CD127 and TCF1 are not reliable markers of CD4 memory precursors, subset-specific programs (Th1 versus Th2 versus Th17) diverge, and the decisive fate-determination factors acting across diverse infections have not been revealed (Liu et al. 2025). Even the textbook CD8 framework has been questioned by a competing model in which some memory cells arise directly from naive cells without passing through an effector stage (Restifo and Gattinoni 2013), and current overviews of immune memory describe CD4 memory generation as incompletely understood (Lam et al. 2024).
Problem Statement
Building on the established effector origin of memory CD4 T cells, determine the mechanisms of the CD4 effector-to-memory transition with one coherent objective: a predictive, causal account of which effector CD4 T cells survive the contraction phase and seed long-lived, functional memory. This jointly requires: (a) identifying the signals (cytokines such as interleukin-2 (IL-2), IL-7 and IL-12, duration of antigen presentation and co-stimulation, inflammatory milieu, anatomical positioning) and the transcriptional and survival programs they engage, that causally determine whether an activated effector CD4 T cell dies during contraction or persists as memory; (b) defining markers or gene-expression signatures that prospectively isolate the memory-seeding effector cells at the peak of the effector response, analogous to the CD8 MPEC/SLEC framework; (c) quantifying the long-term stability, durability and protective recall capacity of memory populations derived from distinct effector progenitors, with the Th1 versus Tfh comparison as the required minimum and other effector subsets optional; and (d) establishing how these mechanisms generalize across pathogens, antigen doses and inflammatory contexts, and which features are conserved versus distinct relative to CD8 T-cell memory differentiation. The question is answered when fate specification, prospective identification, progenitor-dependent recall quality, and the features conserved versus distinct relative to CD8 T-cell memory differentiation are jointly explained by a model grounded in the cited experimental evidence and yielding explicit, testable predictions, with all four parts required (no subset sufficient) and generalization met by at least one representative instance of each of the pathogen, antigen-dose and inflammatory context classes named in (d), not merely by isolated correlative markers in single settings.
References
- Harrington LE, Janowski KM, Oliver JR, Zajac AJ, Weaver CT. Memory CD4 T cells emerge from effector T-cell progenitors. Nature 452, 356-360 (2008). doi:10.1038/nature06672, https://doi.org/10.1038/nature06672
- Löhning M, Hegazy AN, Pinschewer DD, Busse D, Lang KS, Höfer T, Radbruch A, Zinkernagel RM, Hengartner H. Long-lived virus-reactive memory T cells generated from purified cytokine-secreting T helper type 1 and type 2 effectors. Journal of Experimental Medicine 205, 53-61 (2008). doi:10.1084/jem.20071855, https://doi.org/10.1084/jem.20071855
- Pepper M, Jenkins MK. Origins of CD4+ effector and central memory T cells. Nature Immunology 12, 467-471 (2011). doi:10.1038/ni.2038, https://doi.org/10.1038/ni.2038
- Pepper M, Pagán AJ, Igyártó BZ, Taylor JJ, Jenkins MK. Opposing signals from the Bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells. Immunity 35, 583-595 (2011). doi:10.1016/j.immuni.2011.09.009, https://doi.org/10.1016/j.immuni.2011.09.009
- Marshall HD, Chandele A, Jung YW, Meng H, Poholek AC, Parish IA, Rutishauser R, Cui W, Kleinstein SH, Craft J, Kaech SM. Differential expression of Ly6C and T-bet distinguish effector and memory Th1 CD4+ cell properties during viral infection. Immunity 35, 633-646 (2011). doi:10.1016/j.immuni.2011.08.016, https://doi.org/10.1016/j.immuni.2011.08.016
- Van VQ, Raymond M, Baba N, Rubio M, Wakahara K, Susin SA, Sarfati M. CD47high expression on CD4 effectors identifies functional long-lived memory T cell progenitors. Journal of Immunology 188, 4249-4255 (2012). doi:10.4049/jimmunol.1102702, https://doi.org/10.4049/jimmunol.1102702
- Bautista BL, Devarajan P, McKinstry KK, Strutt TM, Vong AM, Jones MC, Kuang Y, Mott D, Swain SL. Short-lived antigen recognition but not viral infection at a defined checkpoint programs effector CD4 T cells to become protective memory. Journal of Immunology 197, 3936-3949 (2016). doi:10.4049/jimmunol.1600838, https://doi.org/10.4049/jimmunol.1600838
- Dhume K, McKinstry KK. Early programming and late-acting checkpoints governing the development of CD4 T-cell memory. Immunology 155, 53-62 (2018). doi:10.1111/imm.12942, https://doi.org/10.1111/imm.12942
- Ciucci T, Vacchio MS, Gao Y, Tomassoni Ardori F, Candia J, Mehta M, Zhao Y, Tran B, Pepper M, Tessarollo L, McGavern DB, Bosselut R. The emergence and functional fitness of memory CD4+ T cells require the transcription factor Thpok. Immunity 50, 91-105.e4 (2019). doi:10.1016/j.immuni.2018.12.019, https://doi.org/10.1016/j.immuni.2018.12.019
- Durek P, Nordström K, Gasparoni G, Salhab A, Kressler C, de Almeida M, Bassler K, Ulas T, Schmidt F, Xiong J, Glažar P, Klironomos F, Sinha A, Kinkley S, Yang X, Arrigoni L, Amirabad AD, Behjati Ardakani F, Feuerbach L, Gorka O, Ebert P, Müller F, Li N, Frischbutter S, Schlickeiser S, Cendon C, Fröhler S, Felder B, Gasparoni N, Imbusch CD, Hutter B, Zipprich G, Tauchmann Y, Reinke S, Wassilew G, Hoffmann U, Richter AS, Sieverling L, Chang HD, Syrbe U, Kalus U, Eils J, Brors B, Manke T, Ruland J, Lengauer T, Rajewsky N, Chen W, Dong J, Sawitzki B, Chung HR, Rosenstiel P, Schulz MH, Schultze JL, Radbruch A, Walter J, Hamann A, Polansky JK. Epigenomic profiling of human CD4+ T cells supports a linear differentiation model and highlights molecular regulators of memory development. Immunity 45, 1148-1161 (2016). doi:10.1016/j.immuni.2016.10.022, https://doi.org/10.1016/j.immuni.2016.10.022
- Soon MSF, Lee HJ, Engel JA, Straube J, Thomas BS, Pernold CPS, Clarke LS, Laohamonthonkul P, Haldar RN, Williams CG, Lansink LIM, Moreira ML, Bramhall M, Koufariotis LT, Wood S, Chen X, James KR, Lönnberg T, Lane SW, Belz GT, Engwerda CR, Khoury DS, Davenport MP, Svensson V, Teichmann SA, Haque A. Transcriptome dynamics of CD4+ T cells during malaria maps gradual transit from effector to memory. Nature Immunology 21, 1597-1610 (2020). doi:10.1038/s41590-020-0800-8, https://doi.org/10.1038/s41590-020-0800-8
- Sun W, Hughes EP, Kim H, Perovanovic J, Charley KR, Perkins B, Du J, Ibarra A, Syage AR, Hale JS, Williams MA, Tantin D. OCA-B/Pou2af1 is sufficient to promote CD4+ T cell memory and prospectively identifies memory precursors. Proceedings of the National Academy of Sciences USA 121, e2309153121 (2024). doi:10.1073/pnas.2309153121, https://doi.org/10.1073/pnas.2309153121
- Liu J, Song W, Tang H. Advances and challenges in identifying precursors of memory CD4+ T cells. Frontiers in Immunology 16, 1540045 (2025). doi:10.3389/fimmu.2025.1540045, https://doi.org/10.3389/fimmu.2025.1540045
- Restifo NP, Gattinoni L. Lineage relationship of effector and memory T cells. Current Opinion in Immunology 25, 556-563 (2013). doi:10.1016/j.coi.2013.09.003, https://doi.org/10.1016/j.coi.2013.09.003
- Lam N, Lee Y, Farber DL. A guide to adaptive immune memory. Nature Reviews Immunology 24, 810-829 (2024). doi:10.1038/s41577-024-01040-6, https://doi.org/10.1038/s41577-024-01040-6